VIRC vs STXS vs ISRG vs FLXS vs SYK

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -1. 1% for Virco Mfg. Corporation (VIRC). Virco Mfg. Corporation (VIRC) offers the better valuation at 4. 7x trailing P/E (8. 5x forward), making it the more compelling value choice. Analysts rate Virco Mfg. Corporation (VIRC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Virco Mfg.

Corporation (VIRC) is the cheapest at 4. 7x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Virco Mfg. Corporation is actually cheaper at 8. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virco Mfg. Corporation wins at 0. 16x versus Intuitive Surgical, Inc. 's 1. 99x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Virco Mfg.

Corporation (VIRC) delivered a total return of +97. 1%, compared to -71. 6% for Stereotaxis, Inc. (STXS). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus STXS's +25. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Stryker Corporation (SYK) is the lower-risk stock at 0.

52β versus Stereotaxis, Inc. 's 1. 73β — meaning STXS is approximately 231% more volatile than SYK relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 66% for Stryker Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -1. 1% for Virco Mfg. Corporation (VIRC). On earnings-per-share growth, the picture is similar: Flexsteel Industries, Inc. grew EPS 85. 9% year-over-year, compared to -11. 1% for Stereotaxis, Inc.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -89. 3% for Stereotaxis, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -91. 9% for STXS. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Virco Mfg. Corporation (VIRC) is the more undervalued stock at a PEG of 0. 16x versus Intuitive Surgical, Inc. 's 1. 99x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virco Mfg. Corporation (VIRC) trades at 8. 5x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 34. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for STXS: 163. 2% to $5. 00.

In this comparison, VIRC (1.

4% yield), SYK (1. 1% yield), FLXS (1. 1% yield) pay a dividend. STXS, ISRG do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

52), 1. 1% yield, +179. 2% 10Y return). Stereotaxis, Inc. (STXS) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SYK: +179. 2%, STXS: +25. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VIRC (Consumer Cyclical) and STXS (Healthcare) and ISRG (Healthcare) and FLXS (Consumer Cyclical) and SYK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VIRC is a small-cap deep-value stock; STXS is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; FLXS is a small-cap deep-value stock; SYK is a mid-cap quality compounder stock. VIRC, FLXS, SYK pay a dividend while STXS, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.